ArticleBMC urology2025
The protective role of ureteral stents in reducing fibrosis and preventing stricture in ureteral injuries of different severities.
Article in BMC urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
purposeUreteral injuries following endoscopic interventions often lead to fibrosis and subsequent stricture formation, yet the optimal use and duration of ureteral stents in preventing these outcomes remain unclear. This study aimed to determine whether ureteral stents have an inhibitory effect on fibrosis development and provide evidence to optimize stent use and duration.
methodsThis study was conducted between March and October 2023. Rabbit models with varying degrees of ureteral injury (G1-G4) were established according to the Post-Ureteroscopy Lesion Scale (PULS), dividing into Control (no ureteral stent placement), 2-week (stent placed for 2 weeks), and 4-week (stent placed for 4 weeks) groups. Ureteral tissues from G1-G4 models were collected at 2- and 4-weeks post-operation for HE staining, Masson staining, RT-PCR, and Western Blot to measure the levels of TGF-β1, α-SMA, and Collagen I expressions.
resultsStent placement in ureteral injury models significantly reduced inflammatory cell infiltration and collagen deposition, thereby mitigating fibrosis, with the most pronounced effects observed in more severe injuries (G3 and G4). At both 2- and 4-weeks post-operation, stented groups showed less inflammation and fibrosis compared to stentless groups, demonstrating the protective effect of stents. The expression of fibrosis-related proteins (TGF-β1, Collagen I, and α-SMA) in ureteral tissues increased with the severity of injury (G1-G4) at both 2- and 4-weeks post-operation.
conclusionsPlacement of a ureteral stent can inhibit fibrosis in G2-G4 level ureteral injuries, preventing ureteral stricture and occlusion. Ureteral stents are suggested to place for more than 4-weeks for injuries beyond the submucosal layer.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.